Onward Medical N.V.

Equities

ONWD

NL0015000HT4

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Bruxelles Other stock markets 11:35:10 2024-05-03 am EDT			5-day change	1st Jan Change
4.87 ^EUR	+2.53%		+3.84%	+57.10%

Apr. 25	Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 02	Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy	MT

Onward Medical N : ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System

April 02, 2024 at 04:35 am EDT

Onward Medical N.V.

Onward Medical N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

Registration date02 apr 2024 - 07:33

Statutory nameOnward Medical N.V.

TitleONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System

Previous result

Next result

Related downloads

202404020000000002_ONWARD Medical Submits Application for ARC-EX(R) to US Food.pdf(opens in a new window)

Date last update: 02 April 2024

Attachments

Original Link
Permalink

Disclaimer

ONWARD Medical NV published this content on 02 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 April 2024 08:34:05 UTC.

Latest news about Onward Medical N.V.

Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy	Apr. 02	MT
Onward Medical Raises EUR20 Million Via Private, Public Offering of Shares	Mar. 21	MT
Onward Medical's Brain-computer Interface Technology Accepted Into US FDA Program	Mar. 11	MT
Onward Medical's ARC-BCI System Receives Breakthrough Designation	Feb. 29	MT
Onward Medical Begins Study of ARC-IM Therapy on Hemodynamic Instability Post Spinal Cord Injury	Jan. 18	MT
Onward Medical N.V. Announces Nature Medicine Publication Highlights Potential for ONWARD ARC Therapy to Improve Mobility After Parkinson's Disease	Nov. 06	CI
Swiss-designed technology helps Parkinson's patient walk again	Nov. 06	RE
Onward Medical N.V. Announces First-in-Human Implant of ARC-IM?? Stimulator with Brain-Computer Interface to Restore Arm, Hand, and Finger Function After Spinal Cord Injury	23-09-27	CI
Onward Medical N.V. Announces CFO Changes	23-09-19	CI
Onward Medical N.V. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-19	CI
Onward Medical Enters Two-year Distribution Deal With Lovell Government Services	23-09-14	MT
Onward(R) Launches Partnership with Service-Disabled Veteran-Owned Business to Access U.S. Federal Health Market	23-09-13	CI
Onward Medical N.V. Announces First-In-Human Use of Arc-Im(Tm) Lead to Restore Movement and Function After Spinal Cord Injury	23-05-15	CI
Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Onward Medical's ARC-EX Platform Secures Breakthrough Device Designation Status from US FDA	23-02-23	MT
Onward Receives New Fda Breakthrough Device Designations for Bladder Control, Alleviation of Spasticity, and Blood Pressure Regulation After Spinal Cord Injury	23-02-23	CI
Onward's Implantable Therapy Raises Blood Pressure Levels of Spinal Cord Injury Patients	22-12-08	MT
Onward Medical N.V. Reports Interim Clinical Outcomes for Implantable ARC Therapy Demonstrating Potential to Improve Blood Pressure Regulation After Spinal Cord Injury	22-12-08	CI
European Innovation Council Awards Second Grant to ONWARD Medical N.V. to Further Develop Brain-Computer Interface Technology	22-11-21	CI
Certain Ordinary Shares of Onward Medical N.V. are subject to a Lock-Up Agreement Ending on 21-OCT-2022.	22-10-20	CI
Onward Medical Reports Positive Study Results for Spinal Cord Injury Home Therapy; Shares Jump 12%	22-10-05	MT
Onward Medical N.V. Announces Topline Results from the LIFT Home Study Supporting Safety and Feasibility of ARC-EX Therapy to Treat People with Spinal Cord Injury At Home	22-10-05	CI
Onward Medical N.V. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-27	CI

Chart Onward Medical N.V.

Duration

Period

More charts

Company Profile

Onward Medical N.V. is a medical technology company developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury and movement disabilities.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-12 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Onward Medical N.V.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.87 EUR

Average target price

13.85 EUR

Spread / Average Target

+184.39%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
ONWARD MEDICAL N.V.	+57.10%	182M
SHOCKWAVE MEDICAL, INC.	+73.37%	12.39B
PENUMBRA, INC.	-17.09%	8.08B
MASIMO CORPORATION	+16.88%	7.25B
GETINGE AB	+3.57%	5.86B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+11.77%	5.35B
APT MEDICAL INC.	+29.65%	4.63B
ASAHI INTECC CO., LTD.	-17.74%	4.19B
INARI MEDICAL, INC.	-35.26%	2.44B
SKAN GROUP AG	+3.09%	2.07B

Medical Equipment